NovoCure Limited
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and NovoTTF-100L, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products that are in Phase 2 pilot and Phase 3 pivotal trials for brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey. Show More...
-
Website http://www.novocure.com
-
Sector Healthcare
-
Industry Medical Instruments & Supplies
-
Last Quote 19.11 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.07 -1.12 -3.67 -1.54 -0.7 -0.69 -0.07 0.1 Dividends USD Payout Ratio % * Shares Mil 72.0 72.0 30.0 86.0 89.0 92.0 97.0 101.0 Book Value Per Share * USD 1.45 1.82 1.3 1.23 1.91 2.41 Free Cash Flow Per Share * USD -1.2 -1.6 -0.6 -0.31 0.28 Return on Assets % -40.96 -52.6 -52.48 -44.74 -22.53 -21.01 -1.77 2.03 Financial Leverage (Average) 1.1 1.2 1.23 1.98 2.34 3.03 2.2 2.08 Return on Equity % -45.04 -59.84 -64.0 -67.07 -48.19 -56.29 -4.38 4.82 Return on Invested Capital % -42.35 -59.74 -59.23 -50.22 -24.96 -23.52 0.12 2.57 Interest Coverage -9.76 -44.15 -19.46 -3.73 -2.41 0.36 Current Ratio 11.76 6.33 10.27 7.1 4.88 4.98 5.1 5.49 Quick Ratio 11.53 6.08 9.74 6.34 4.34 4.54 4.77 5.21 Debt/Equity 0.09 0.68 0.86 1.33 0.75 0.67